kabutan

Japan Tissue Engineering, The Current Fiscal Year Ordinary Profit Revised Downward to a Loss

Fri Jan 31, 2025 3:30 pm JST Earnings

7774 Japan Tissue Engineering Co., Ltd. 【J-GAAP】

Earnings Report

Japan Tissue Engineering Co., Ltd. <7774> [TSE Growth] announced its financial results after the market closed on January 31st (15:30). The ordinary loss (non-consolidated) for the cumulative third quarter of the fiscal year ending March 2025 (April to December) expanded to a loss of 330 million yen (compared to a loss of 50 million yen in the same period last year).

In addition, the full-year ordinary profit/loss has been revised downward from an expected profit of 123 million yen to a loss of 202 million yen (compared to a profit of 147 million yen in the previous period), turning to a loss outlook.

Based on the full-year plan announced by the company after the downward revision, our estimate of the ordinary profit for the October to March period (2H) has decreased 98.8%, from the previous forecast of 329 million yen to 4 million yen (compared to 156 million yen in the same period of the previous year). This changes the outlook from an anticipated profit increase to a projection of a 97.4% decrease in profit.

In the most recent three-month period, from October to December (3Q), the ordinary loss expanded to a loss of 124 million yen (compared to a loss of 41 million yen in the same period last year). The operating profit/loss margin drastically worsened from -7.6% in the same period last year to -22.8%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Dec, 2022 1,443 -624 -622 -625 -15.4 ー Jan 27, 2023 J-GAAP
Apr - Dec, 2023 1,785 -51 -50 -53 -1.3 ー Jan 30, 2024 J-GAAP
Apr - Dec, 2024 1,706 -331 -330 -350 -8.6 ー Jan 31, 2025 J-GAAP
YoY -4.4% -549.0% -560.0% -560.4% -553.0%

Guidance Update

Second Half Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 Prev 1,783 327 329 312 7.7 0 Oct 31, 2024 J-GAAP
Oct - Mar, 2024 New 1,339 7 4 2 0.1 0 Jan 31, 2025 J-GAAP
Revision Rate -24.9% -97.9% -98.8% -99.4% -99.3%

Full Year Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2025 Prev 2,944 120 123 87 2.1 0 Apr 30, 2024 J-GAAP
Mar, 2025 New 2,500 -200 -202 -223 -5.5 0 Jan 31, 2025 J-GAAP
Revision Rate -15.1% － － － －

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2023 1,268 154 156 154 3.8 0 Apr 30, 2024 J-GAAP
Oct - Mar, 2024 Guidance 1,339 7 4 2 0.1 0 Jan 31, 2025 J-GAAP
YoY +5.6% -95.5% -97.4% -98.7% -98.7%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 2,032 -728 -725 -729 -18.0 0 Apr 27, 2023 J-GAAP
Mar, 2024 2,514 144 147 143 3.5 0 Apr 30, 2024 J-GAAP
Mar, 2025 Guidance 2,500 -200 -202 -223 -5.5 0 Jan 31, 2025 J-GAAP
YoY -0.6% － － － －

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2023 539 -41 -41 -42 -1.1 -7.6 Jan 30, 2024 J-GAAP
Jan - Mar, 2024 729 195 197 196 4.8 26.7 Apr 30, 2024 J-GAAP
Apr - Jun, 2024 442 -193 -192 -211 -5.2 -43.7 Jul 30, 2024 J-GAAP
Jul - Sep, 2024 719 -14 -14 -14 -0.4 -1.9 Oct 31, 2024 J-GAAP
Oct - Dec, 2024 545 -124 -124 -125 -3.1 -22.8 Jan 31, 2025 J-GAAP
YoY +1.1% -202.4% -202.4% -197.6% -193.3%

Related Articles